Analysis
Déjà Vu: GSK Recycles Its Problematic Adjuvant into Covid-19 Vaccines
Déjà Vu: GSK Recycles Its Problematic Adjuvant into Covid-19 Vaccines Authored and Contributed to TLB by: The Children’s Health Defense Team Among the 100 or so global players now working on experimental Covid-19 vaccines, most […]
